ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
66.862,17
-0,33%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Johnson and Johnson (JNJ)

  7. Johnson and Johnson (JNJ) News

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:JNJ
DatumZeitQuelleÜberschriftSymbolFirma
17/05/202417h21Edgar (US Regulatory)Form 8-K - Current reportNYSE:JNJJohnson and Johnson
17/05/202413h36IH Market NewsOpenAI’s Reddit Partnership Boosts Shares by 14%, Microsoft Embraces AMD Chips for AI, and More NewsNYSE:JNJJohnson and Johnson
16/05/202422h16Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JNJJohnson and Johnson
16/05/202413h30Business WireJohnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis TreatmentNYSE:JNJJohnson and Johnson
14/05/202423h01Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:JNJJohnson and Johnson
14/05/202413h26IH Market NewsWalmart Corporate Job Cuts and Office Centralization, GameStop and AMC Surge, and More NewsNYSE:JNJJohnson and Johnson
14/05/202412h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:JNJJohnson and Johnson
13/05/202414h36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:JNJJohnson and Johnson
10/05/202423h14Edgar (US Regulatory)Form 13F-HR - Quarterly report filed by institutional managers, HoldingsNYSE:JNJJohnson and Johnson
08/05/202422h30Business WireJohnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
06/05/202422h05GlobeNewswire Inc.Shockwave Medical Reports First Quarter 2024 Financial ResultsNYSE:JNJJohnson and Johnson
01/05/202412h30Business WireJohnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” ReorganizationNYSE:JNJJohnson and Johnson
22/04/202422h30Business WireJohnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)NYSE:JNJJohnson and Johnson
19/04/202413h31IH Market NewsParamount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and MoreNYSE:JNJJohnson and Johnson
17/04/202412h59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202422h33IH Market NewsU.S. Stocks Finish Lackluster Session Narrowly MixedNYSE:JNJJohnson and Johnson
16/04/202416h46Business WireCORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
16/04/202415h52IH Market NewsJ&J’s Q1 2024 sales rise 2.3% to $21.4 billionNYSE:JNJJohnson and Johnson
16/04/202415h09IH Market NewsDow Looks To Snap Six-Day Losing Streak As UnitedHealth SurgesNYSE:JNJJohnson and Johnson
16/04/202413h19IH Market NewsU.S. Index Futures Signal Mixed Trading, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202413h18IH Market NewsEricsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More NewsNYSE:JNJJohnson and Johnson
16/04/202412h25Business WireJohnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%NYSE:JNJJohnson and Johnson
16/04/202412h20Business WireJohnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
15/04/202422h38IH Market NewsU.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales DataNYSE:JNJJohnson and Johnson
09/04/202400h06Business WireJohnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
06/04/202405h21PR Newswire (US)CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of TherapyNYSE:JNJJohnson and Johnson
05/04/202420h55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.NYSE:JNJJohnson and Johnson
05/04/202413h38IH Market NewsApple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More UpdatesNYSE:JNJJohnson and Johnson
05/04/202412h31Business WireJohnson & Johnson to Acquire Shockwave MedicalNYSE:JNJJohnson and Johnson
05/04/202400h01Business WireJohnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment CorporationNYSE:JNJJohnson and Johnson
 Showing the most relevant articles for your search:NYSE:JNJ

Kürzlich von Ihnen besucht

NASDAQ
QOMOR
Qomolangma Acquisition
BIT
P20WJ6
NLBNPIT20WJ6 20241220 36
EU
BN56B
Bnp Paribas null
BIT
P20TL8
NLBNPIT20TL8 20351221 5....
BITMOT
871247
Eib Tf 3,75% Lg24 Rub
BIT
P1WRG6
NLBNPIT1WRG6 20351221 81...
BIT
P1X0C0
NLBNPIT1X0C0 20240920 200
EU
H928T
H928T
ASX
CIMKOB
BIT
P1V3D4
NLBNPIT1V3D4 20351221 92...
BIT
P21FR2
NLBNPIT21FR2 20241220 38...
LSE
TSGB
Vaneck Esg Ew
BIT
P1ZJC5
NLBNPIT1ZJC5 20240918 18...
BIT
P1VYP5
NLBNPIT1VYP5 20991231 5....
EU
A021Y
Hsbc Continental Europe ...
BIT
P1ZLV1
NLBNPIT1ZLV1 20240621 33...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten